Used as a key intermediate in the synthesis of kinase inhibitors, particularly in pharmaceutical research targeting cancer therapies. It serves as a building block for compounds that modulate protein kinases involved in cell signaling, proliferation, and apoptosis. Its structure allows for selective modification to enhance binding affinity and specificity toward target enzymes. Commonly employed in the development of small-molecule drugs for oncology, especially in programs focused on tyrosine kinase and cyclin-dependent kinase inhibition. Also utilized in medicinal chemistry for scaffold optimization during lead compound development.